Track Vext Science, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Vext Science, Inc. VEXTF · Stock Open Vext Science, Inc. in new tab

0.1789 USD
EPS
-0.06
P/B
0.82
ROE
-22.98
Beta
0.81
Vext Science, Inc. logo

Vext Science, Inc.

🧾 Earnings Recap – Q2 2026

Shares rose 4.2% following Q2 as margin expansion and successful execution on the Arizona cultivation exit and Ohio expansion outweighed flat revenue and earlier pricing missteps.

  • Revenue was $12.1 million, roughly flat sequentially but down 10% year-over-year, reflecting a planned pullback in Arizona wholesale.
  • Gross margin improved substantially to 55% from 36% a year ago, driven by higher retail mix and better cultivation yields surpassing 100 grams per plant.
  • Adjusted EBITDA increased for the second consecutive quarter, underscoring ongoing profitability progress despite top-line pressures.
  • Ohio retail continues to drive growth including a new dispensary opened in June; however, a pricing error on flower in Ohio temporarily cost volume but has since been corrected.
  • Arizona cultivation was wound down as planned amid declining state market sales and unattractive wholesale prices; focus shifted to third-party sourcing and operating two dispensaries, with customer traffic rebounding notably.
📅
Loading chart...
Key Metrics
Earnings dateNov. 19, 2026
EPS-0.06
Book Value0.22
Price to Book0.82
Debt/Equity62.33
% Insiders45.689%
Growth
Revenue Growth-0.10%
Estimates
Forward P/E-6.43
Forward EPS-0.03

DCF Valuation

Tweak assumptions to recompute fair value for Vext Science, Inc. (VEXTF)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Vext Science, Inc. Logo Vext Science, Inc. Analysis (VEXTF)

Canada Health Care Official Website Stock

Is Vext Science, Inc. a good investment? Vext Science, Inc. (VEXTF) is currently trading at 0.1789 USD.

Earnings Schedule: Vext Science, Inc. is expected to release its next earnings report on Nov. 19, 2026. The market consensus estimate for Forward EPS is -0.03.

Investor FAQ

Does Vext Science, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Vext Science, Inc.?

Vext Science, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 19, 2026. The company currently has a trailing EPS of -0.06.

Company Profile

Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.

Exchange Ticker
CNQ (Canada) VEXT.CN
FRA (Germany) VV5.F
PNK (United States) VEXTF
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion